STD Testing for Fertility Patients in Kathmandu Mandatory Screening Before IUI, IVF and Conception

Overview

STD testing for fertility patients is not optional — it is a mandatory part of responsible fertility care. Sexually transmitted infections, particularly chlamydia and gonorrhea, are leading preventable causes of pelvic inflammatory disease (PID), tubal damage and infertility. For couples pursuing IUI (intrauterine insemination), IVF (in vitro fertilization), or natural conception after difficulty, screening both partners for STIs is essential before any procedure begins.

The reasons are both protective and practical. Untreated chlamydia or gonorrhea can ascend from the cervix to the uterus and fallopian tubes, causing PID — inflammation that scars the tubes and renders them unable to transport eggs. Performing IUI or IVF in the presence of an untreated cervical infection risks introducing bacteria into the uterus, potentially causing a more severe infection. Screening identifies and treats these infections before procedures, protecting both the patient and the potential pregnancy.

Beyond chlamydia and gonorrhea, fertility screening panels include HIV, syphilis, hepatitis B and C, and sometimes rubella and other infections relevant to pregnancy. Both partners should be screened because either could carry an infection that affects fertility or could be transmitted during conception or pregnancy. Male partners are tested because infections can affect sperm quality and because untreated STIs in men can be transmitted to women.

This page explains which tests are mandatory for fertility patients, why each matters, how the testing process works, what happens if a result is positive, and how Thamel Clinic coordinates STD screening with fertility treatment plans. We work alongside fertility specialists to ensure screening is completed and cleared before any procedure begins.

Why STD Screening Is Mandatory for Fertility Patients

STD screening before fertility treatment is mandatory because untreated infections can cause serious harm during procedures and to future pregnancies. Chlamydia and gonorrhea are the most critical — these bacteria can ascend from the cervix into the uterus and fallopian tubes, causing pelvic inflammatory disease. PID scars the tubes, blocks them, or damages the delicate lining needed for fertilization and implantation. For women already struggling with infertility, an untreated infection can eliminate remaining fertility.

The risk is not only to the woman. Performing IUI or IVF in the presence of an untreated cervical infection introduces bacteria directly into the uterus through the catheter, potentially causing endometritis (uterine infection) or worse. For IVF, infection can affect embryo transfer success and pregnancy outcomes. For IUI, the catheter bypasses the cervix's natural barrier, making infection control even more critical.

Male partners must also be screened. Untreated STIs in men can be transmitted to women during conception attempts, potentially causing PID after intercourse. Some infections may also affect sperm quality or function. Screening both partners ensures that conception attempts do not introduce infection and that any existing infections are treated before procedures begin.

• Untreated chlamydia/gonorrhea causes PID — tubal scarring and infertility
• IUI/IVF in presence of infection risks uterine infection
• Catheter procedures bypass natural cervical barriers
• Male partner infections can be transmitted during conception
• Both partners must be screened and cleared before procedures
• Early treatment protects remaining fertility and future pregnancy

Tests Included in Fertility Screening

A complete fertility STD panel includes several tests designed to detect infections that affect reproductive health. Chlamydia and gonorrhea are tested by NAAT (nucleic acid amplification test) — the most sensitive and specific method — using urine samples for both men and women, or swabs for women if preferred. These tests detect the bacteria even when there are no symptoms.

HIV screening uses fourth-generation antigen-antibody tests that detect infection earlier than older tests. Syphilis is screened with treponemal and non-treponemal serology. Hepatitis B is tested with HBsAg (surface antigen), and hepatitis C with antibody testing. Some fertility panels also include rubella immunity testing (critical for pregnancy planning) and, in some cases, HSV serology if there is clinical indication.

The panel may be customized based on the couple's history, risk factors, and the specific fertility treatment planned. For example, couples undergoing IVF may need additional infectious disease screening as required by the fertility clinic. Your fertility specialist will specify which tests are required, and Thamel Clinic coordinates the testing to meet those requirements.

• Chlamydia and gonorrhea — NAAT on urine or swab (most sensitive)
• HIV — fourth-generation antigen-antibody test
• Syphilis — treponemal and non-treponemal serology
• Hepatitis B — HBsAg surface antigen
• Hepatitis C — antibody screening
• Optional: rubella immunity, HSV serology based on clinical need

How Testing Works

Both partners attend for testing — either together or separately, whichever is more comfortable. A pre-test counseling session explains what is being tested, why it matters for fertility, and how results will be handled. No partner's results are disclosed to the other without explicit consent. For women, urine or swab samples are collected for chlamydia/gonorrhea; for men, urine is typically sufficient.

Blood samples are drawn for HIV, syphilis and hepatitis testing. The entire process takes about 15–20 minutes including counseling. Most results are available within 1–3 working days from the laboratory. Results are communicated privately by a clinician who explains what each result means in the context of fertility treatment.

If all results are negative, the couple receives documentation of STD clearance that can be shared with their fertility clinic or specialist as required. If any result is positive, the process shifts to confirmatory testing and treatment — the fertility procedure is postponed until the infection is treated and clearance is confirmed. This delay protects both the patient and any future pregnancy.

• Both partners tested independently — privacy maintained
• Pre-test counseling explains fertility relevance and confidentiality
• Urine/swab for chlamydia/gonorrhea; blood for HIV, syphilis, hepatitis
• Process takes 15–20 minutes including counseling
• Results available within 1–3 working days
• Clearance documentation provided for fertility clinic

If a Result Is Positive

A positive screening result is always confirmed before diagnosis — reactive tests are not diagnoses. Once confirmed, the infection is treated promptly. Chlamydia and gonorrhea are curable with antibiotics; treatment typically takes 7 days and must be completed before fertility procedures resume. Syphilis is also curable with penicillin or appropriate antibiotics.

HIV and hepatitis B/C require different management. HIV is managed with antiretroviral therapy — with proper treatment, people with HIV can have healthy pregnancies and protect their partners and babies. Hepatitis B may require monitoring and sometimes treatment; hepatitis C is now curable with modern antivirals. These conditions do not necessarily prevent fertility treatment, but they require coordination with specialists.

After treatment for bacterial infections, test-of-cure is performed to confirm the infection has cleared before fertility procedures proceed. Both partners are retested to ensure no reinfection. The fertility clinic is informed of clearance status, and procedures are scheduled only after confirmation that all infections are treated and cleared.

• Reactive screens confirmed before diagnosis
• Chlamydia/gonorrhea curable with 7-day antibiotic courses
• Syphilis curable with penicillin or appropriate antibiotics
• HIV managed with antiretrovirals — healthy pregnancy possible
• Hepatitis C curable with modern antivirals; HBV requires monitoring
• Test-of-cure confirms clearance before procedures resume

Coordination with Fertility Treatment

STD screening for fertility patients is most effective when coordinated with the fertility treatment plan. At Thamel Clinic, we work with fertility specialists and clinics to ensure screening is completed at the right time, results are communicated appropriately, and any positive findings are managed before procedures begin. This coordination prevents delays and ensures compliance with fertility clinic requirements.

For couples undergoing IUI, the screening must be completed and cleared before the procedure. For IVF, additional infectious disease screening may be required by the fertility clinic, and coordination ensures all requirements are met. For couples trying naturally after difficulty conceiving, screening identifies treatable infections that may be contributing to infertility.

We also provide ongoing support — retesting after treatment, monitoring for reinfection, and counseling on preventing STIs during fertility treatment. This comprehensive approach ensures that sexual health supports rather than hinders the fertility journey.

• Coordination with fertility specialists and clinics
• Screening completed before IUI or IVF procedures
• Additional infectious disease screening for IVF as required
• Retesting after treatment to confirm clearance
• Monitoring for reinfection during fertility treatment
• Counseling on preventing STIs during conception attempts

Fertility STD Screening Services and Costs

Prices are indicative in NPR; confirm current rates when booking. Lab charges may be billed separately.

Related Services & Guides